Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRVASE balanced versus saline fluid resuscitation in ICU shock patients
2009-014382-12Phase 4Active
- Sponsor
- Institut d'Anesthésiologie des Alpes Maritimes
- Start
- Jul 2009
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of sterofundin, hydroxyethyl starch 130/0.42 and sodium chloride in Shock (2 arms), sponsored by Institut d'Anesthésiologie des Alpes Maritimes. Primary endpoint: Incidence and severity of hyperchloremic acidosis. Started Jul 2009; status: active.
02
Drugs
sterofundinhydroxyethyl starch 130/0.42sodium chloride
03
Conditions
Shock
Beyond the preview
Go deeper on 2009-014382-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014382-12.